Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067613 · ClinicalTrials.gov registry record · NA
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
A NA study, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- NA
- Development phase
- 4,095
- Enrollment target
NCT00067613: Completed NA study, sponsored by NICHD Neonatal Research Network.
NCT00067613 is a NA study that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 4,095 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (192% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00067613, a NA study, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,095 participants
- Enrollment target
Study Summary
This study tested whether Neonatal Intensive Care Unit (NICU) teams trained in benchmarking -- comparing care practices between different NICUs to see which practices prevent bronchopulmonary dysplasia (BPD) -- and quality improvement would change practices and improve rates of survival without BPD in inborn neonates with birth weights of \<1250 grams. Benchmarking is a method involving detailed comparisons of processes between similar organizations. For this study, three NRN centers with the lowest rates of BPD have been identified as Benchmark centers. During a 6-month pre-intervention period, details of care practices and management style at these centers were carefully assessed. Based on practices at these Benchmarking sites, we developed a quality improvement program. For this study, 14 other NRN sites were randomized to either implement the benchmarking intervention (intervention sites) or continue with their usual care practices (control sites). After the 1-year intervention period, we compared changes in the rate of survival without BPD at 36 weeks corrected age between the intervention and control sites.
Interventions
- OTHER Benchmarking Management Practices
- OTHER Standard Management Practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,095 participants |
| Start Date | 2001-03 |
| Est. Completion | 2004-05 |
| Phase | NA |
What the finished NCT00067613 record still lists
NCT00067613 is an interventional study that assigns participants to a tested intervention. Its 4,095 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (192% higher).
The record links to 0 conditions, and to 2 interventions - of which Benchmarking Management Practices is the first listed.
NCT00067613 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00067613 about?
NCT00067613 is a clinical study titled "Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia". This study tested whether Neonatal Intensive Care Unit (NICU) teams trained in benchmarking -- comparing care practices between different NICUs to see which practices prevent bronchopulmonary dysplasia (BPD) -- and quality improvement would change practices and improve rates of survival without BPD ...
What is the current status of trial NCT00067613?
This trial is currently completed. It is a NA study. The enrollment target is 4,095 participants. The study started on 2001-03. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00067613?
The interventions under investigation include: Benchmarking Management Practices (OTHER), Standard Management Practices (OTHER).
Who is sponsoring clinical trial NCT00067613?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00067613's enrollment target sits among peer trials
4,095 32nd of 2000 higher than 1,969 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03388606 · 4,100 participants
Characterization and Treatment of Adolescent Depression
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia